Atrial fibrillation patients who took digoxin had a 41% higher risk of death from all causes than those who didn't take the drug, according to a study of more than 4,000 patients. In addition, digoxin users were 35% more likely to die from cardiovascular causes and 61% more likely to die from arrhythmias than non-users. The findings were published online in the European Heart Journal.
Digoxin raises mortality risk in A-fib patients, study finds
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan